Implementation of goal-directed fluid therapy during hip revision arthroplasty: a matched cohort study

被引:0
|
作者
Habicher, Marit [1 ,2 ]
Balzer, Felix [1 ,2 ]
Mezger, Viktor [1 ,2 ]
Niclas, Jennifer [1 ,2 ]
Mueller, Michael [2 ]
Perka, Carsten [2 ,3 ]
Kraemer, Michael [1 ,2 ,3 ]
Sander, Michael [1 ,4 ]
机构
[1] Campus Charite Mitte, Charite Univ Hosp Berlin, Dept Anaesthesiol & Intens Care Med, Berlin, Germany
[2] Campus Virchow Klinikum, Berlin, Germany
[3] Campus Charite Mitte, Charite Univ Hosp Berlin, Dept Orthopaed, Ctr Musculoskeletal Surg, Berlin, Germany
[4] Justus Liebig Univ, Dept Anaesthesiol Intens Care Med & Pain Therapy, Giessen, Germany
关键词
Goal-directed fluid therapy; Hip surgery; Postoperative outcome; Haemodynamic monitoring; Hip revision arthroplasty;
D O I
10.1186/s13741-016-0056-x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Several randomized controlled trials (RCTs) have demonstrated that intraoperative goal-directed fluid therapy (GDFT) can decrease postsurgical complications in patients undergoing major abdominal surgery. However, very few studies have demonstrated the value of goal-directed therapy (GDT) in patients undergoing orthopaedic surgery and confirmed it is as useful in real-life conditions. Therefore, we initiated a GDFT implementation programme in patients undergoing hip revision arthroplasty in order to assess its effects on postoperative complications (e.g. infection, cardiac, neurological, renal) (primary outcome) and hospital and intensive care unit (ICU) length of stay (secondary outcomes). Methods: We developed a GDFT protocol for the haemodynamic management of patients undergoing hip revision arthroplasty. The GDFT protocol was based on continuous monitoring and optimization of stroke volume during the surgical procedure. From December 2012 and for a period of 17 months, 130 patients were treated according to the GDFT protocol (GDFT group). The pre-, intra-, and postoperative characteristics of patients from the GDFT group were compared to those of 130 historical matched patients (control group) who had the same surgery between January 2011 and August 2012. Results: Patients from the GDFT and from the control group were comparable in terms of age, comorbidities, and P-POSSUM score. Duration of anaesthesia and surgery were also comparable. The GDFT group had a significantly lower morbidity rate (49.2 vs. 66.9%; p = 0.006) and a shorter median hospital length of stay (11 days (9-15) vs. 9 days (8-12); p = 0.003) than the control group. Patients from the control group post-anaesthesia care unit (PACU)/ICU stayed significantly longer at PACU/ICU than patients from the GDFT group (control group vs. GDFT group, 960 min (360-1210) vs. 400 min (207-825); p < 0.001) Patients from the GDFT group received less crystalloids but more colloids during surgery. They also received more often inotropic therapy. Conclusions: In patients undergoing hip revision arthroplasty, the implementation of GDT as a new standard operating procedure was successful and associated with reduced postsurgical complications, most importantly a reduction in postoperative bleeding as well as hospital and ICU stay.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] When is enough enough? Individualized goal-directed fluid therapy for surgery
    Secher, Niels H.
    JOURNAL OF CLINICAL MONITORING AND COMPUTING, 2013, 27 (03) : 223 - 224
  • [42] Reply to: crystalloids should be second choice for goal-directed fluid therapy
    Laszlo, Ildiko
    Janovszky, Agnes
    Szabo, Andrea
    Molnar, Zsolt
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2020, 37 (05) : 415 - 416
  • [43] Crystalloids versus colloids for goal-directed fluid therapy in major surgery
    Hiltebrand, Luzius B.
    Kimberger, Oliver
    Arnberger, Michael
    Brandt, Sebastian
    Kurz, Andrea
    Sigurdsson, Gisli H.
    CRITICAL CARE, 2009, 13 (02):
  • [45] The impact of intraoperative goal-directed fluid therapy on complications after pancreaticoduodenectomy
    Sulzer, Jesse K.
    Sastry, Amit, V
    Meyer, Lauren M.
    Cochran, Allyson
    Buhrman, William C.
    Baker, Erin H.
    Martinie, John B.
    Iannitti, David A.
    Vrochides, Dionisios
    ANNALS OF MEDICINE AND SURGERY, 2018, 36 : 23 - 28
  • [46] Goal-directed Fluid Therapy in Neurosurgery: Three Feet from Gold?
    Kothekar, Amol T.
    Mohanty, Rakesh
    Joshi, Anand Vinaykumar
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2023, 27 (10) : 697 - 698
  • [47] When is enough enough? Individualized goal-directed fluid therapy for surgery
    Niels H. Secher
    Journal of Clinical Monitoring and Computing, 2013, 27 : 223 - 224
  • [48] ERAS Without Intraoperative Goal-Directed Fluid Therapy Is Still ERAS
    Engelman, Daniel T.
    ANNALS OF THORACIC SURGERY, 2022, 114 (06): : 2065 - 2066
  • [49] Crystalloids versus colloids for goal-directed fluid therapy in major surgery
    Luzius B Hiltebrand
    Oliver Kimberger
    Michael Arnberger
    Sebastian Brandt
    Andrea Kurz
    Gisli H Sigurdsson
    Critical Care, 13
  • [50] Research progress of goal-directed fluid therapy in prone position surgery
    Wei, Yuqing
    Wang, Chengping
    Sun, Lin
    Wang, Danyang
    Chen, Peng
    MINERVA ANESTESIOLOGICA, 2022, 88 (12) : 1057 - 1065